AKAN
Price
$1.29
Change
-$0.04 (-3.01%)
Updated
Nov 13 closing price
Capitalization
939.49K
Intraday BUY SELL Signals
HNSPF
Price
Loading...
Change
-$0.00 (-0.00%)
Updated
Loading...
Capitalization
29.46B
Intraday BUY SELL Signals
Interact to see
Advertisement

AKAN vs HNSPF

Header iconAKAN vs HNSPF Comparison
Open Charts AKAN vs HNSPFBanner chart's image
Akanda
Price$1.29
Change-$0.04 (-3.01%)
Volume$1.39M
Capitalization939.49K
Hansoh Pharmaceutical Group
PriceLoading...
Change-$0.00 (-0.00%)
Volume$100
Capitalization29.46B
AKAN vs HNSPF Comparison Chart in %
AKAN
Daily Signal:
Gain/Loss:
HNSPF
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
AKAN vs. HNSPF commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AKAN is a Hold and HNSPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (AKAN: $1.29 vs. HNSPF: $5.00)
Brand notoriety: AKAN and HNSPF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: AKAN: 97% vs. HNSPF: 37%
Market capitalization -- AKAN: $939.49K vs. HNSPF: $29.46B
AKAN [@Pharmaceuticals: Generic] is valued at $939.49K. HNSPF’s [@Pharmaceuticals: Generic] market capitalization is $29.46B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AKAN’s FA Score shows that 0 FA rating(s) are green whileHNSPF’s FA Score has 2 green FA rating(s).

  • AKAN’s FA Score: 0 green, 5 red.
  • HNSPF’s FA Score: 2 green, 3 red.
According to our system of comparison, HNSPF is a better buy in the long-term than AKAN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AKAN’s TA Score shows that 4 TA indicator(s) are bullish while HNSPF’s TA Score has 4 bullish TA indicator(s).

  • AKAN’s TA Score: 4 bullish, 3 bearish.
  • HNSPF’s TA Score: 4 bullish, 2 bearish.
According to our system of comparison, HNSPF is a better buy in the short-term than AKAN.

Price Growth

AKAN (@Pharmaceuticals: Generic) experienced а -3.01% price change this week, while HNSPF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.08%. For the same industry, the average monthly price growth was -3.24%, and the average quarterly price growth was +32.16%.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HNSPF($29.5B) has a higher market cap than AKAN($939K). HNSPF has higher P/E ratio than AKAN: HNSPF (44.46) vs AKAN (0.04). HNSPF YTD gains are higher at: 134.390 vs. AKAN (-74.200).
AKANHNSPFAKAN / HNSPF
Capitalization939K29.5B0%
EBITDA-3.03MN/A-
Gain YTD-74.200134.390-55%
P/E Ratio0.0444.460%
Revenue837KN/A-
Total Cash3.84MN/A-
Total Debt353KN/A-
TECHNICAL ANALYSIS
Technical Analysis
AKANHNSPF
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
17%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
20%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
30%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
27%
Advances
ODDS (%)
Bullish Trend about 1 month ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
AKAN
Daily Signal:
Gain/Loss:
HNSPF
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFWM5.06-0.02
-0.39%
First Foundation
BHFAM11.50-0.30
-2.54%
Brighthouse Financial
CR185.71-5.27
-2.76%
Crane Company
EYE23.67-1.07
-4.32%
National Vision Holdings
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics

HNSPF and

Correlation & Price change

A.I.dvisor tells us that HNSPF and RMTI have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HNSPF and RMTI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HNSPF
1D Price
Change %
HNSPF100%
N/A
RMTI - HNSPF
24%
Poorly correlated
-9.04%
AYURF - HNSPF
11%
Poorly correlated
N/A
AKAN - HNSPF
8%
Poorly correlated
-0.75%
IXHL - HNSPF
5%
Poorly correlated
+3.50%
BFRI - HNSPF
4%
Poorly correlated
-6.37%
More